Major pharmacy companies agree to settle in nationwide opioid cases
CVS and Walgreens, two of the largest pharmacy chains in the country, have agreed to pay $5 billion each to settle lawsuits throughout the country over allegations of mishandling opioid prescriptions. The companies announced the settlement plan through government filings but need the approval of the myriad of plaintiffs before the deal can go into effect, The New York Times reports.
These settlements can potentially put an end to the decades of lawsuits regarding the role of the drug industry in the opioid epidemic, NPR reports. Opioid overdose was the cause of 80,000 deaths in 2021 alone and approximately 9.5 million Americans reported misusing opioids in 2020, according to CNN. Opioids are painkillers that can be illegal, like heroin, or prescribed by doctors, including morphine, oxycodone, and hydrocodone.
Previously, the companies tried fighting the lawsuits in court; they were unsuccessful, however, when a federal judge ordered them to pay $650 million to two Ohio counties in August, the Times continues. The jury explained that the companies seemed to turn a blind eye to alarming pill quantities and continued to dispense.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
CVS and Walgreens have specified that their willingness to pay settlements does not equate to an admission of wrongdoing. Along with CVS and Walgreens, Walmart has agreed to pay $3 billion in settlements as well.
CVS general counsel Thomas Moriarty said in a statement, "We are committed to working with states, municipalities, and tribes, and will continue our own important initiatives to help reduce the illegitimate use of prescription opioids."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Nnela Kalu’s historic Turner Prize winTalking Point Glasgow-born artist is first person with a learning disability to win Britain’s biggest art prize
-
Bridget Riley: Learning to See – an ‘invigorating and magical ensemble’The Week Recommends The English artist’s striking paintings turn ‘concentration into reverie’
-
‘Stakeknife’: MI5’s man inside the IRAThe Explainer Freddie Scappaticci, implicated in 14 murders and 15 abductions during the Troubles, ‘probably cost more lives than he saved’, investigation claims
-
Stopping GLP-1s raises complicated questions for pregnancyThe Explainer Stopping the medication could be risky during pregnancy, but there is more to the story to be uncovered
-
Nitazene is quietly increasing opioid deathsThe explainer The drug is usually consumed accidentally
-
More adults are dying before the age of 65Under the radar The phenomenon is more pronounced in Black and low-income populations
-
Ultra-processed AmericaFeature Highly processed foods make up most of our diet. Is that so bad?
-
Tips for surviving loneliness during the holiday season — with or without peoplethe week recommends Solitude is different from loneliness
-
More women are using more testosterone despite limited researchThe explainer There is no FDA-approved testosterone product for women
-
Climate change is getting under our skinUnder the radar Skin conditions are worsening because of warming temperatures
-
Is this the end of ultraprocessed foods?Today's Big Question California law and the MAHA movement are on the same track
